Le Lézard
Classified in: Science and technology
Subject: CCA

General Dynamics to Webcast 2024 First-Quarter Financial Results Conference Call


RESTON, Va., April 4, 2024 /PRNewswire/ -- General Dynamics (NYSE: GD) will webcast its first-quarter 2024 earnings results conference call on Wednesday, April 24, beginning at 9 a.m. EDT.

The live webcast of the conference call will be available at www.gd.com. A replay will be available shortly after the live presentation.  

More information about General Dynamics is available at www.gd.com.

General Dynamics (PRNewsFoto/General Dynamics) (PRNewsFoto/General Dynamics)

 

SOURCE General Dynamics


These press releases may also interest you

at 18:00
BetterLife Announces Intent to Complete Private Placement of Units
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...

at 17:45
Celonis Appoints Mark Jacobs as Go-to-Market Leader for North America
Celonis, the global leader in Process Mining, today announced it has appointed Mark Jacobs to the role of Senior Vice President North America Sales. As the Go-to-Market leader for North America, Jacobs will work closely with new and existing...

at 17:05
DXC Technology to Participate in Upcoming Investor Conferences
DXC Technology , a leading Fortune 500 global technology services company, today announced it will participate in the following investor conferences: J.P. Morgan's Technology, Media, & Telecom 2024 Conference ? Raul Fernandez, President and CEO, is...

at 17:05
Intercontinental Exchange, Inc. Commences Private Exchange Offer for Black Knight InfoServ LLC's Outstanding 3.625% Senior Notes due 2028
Intercontinental Exchange, Inc. ("ICE") announced today that it is commencing a private exchange offer (the "Exchange Offer") with respect to the outstanding 3.625% Senior Notes due 2028 (the "BK Notes") issued by Black Knight InfoServ, LLC, a...

at 17:00
Spyre Therapeutics Announces Grants of Inducement Awards
Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel...

at 17:00
Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals
Sentynl...

More news about Science and technology...


News published on and distributed by: